According to Intent Market Research, the Digital Pathology Market is expected to grow from USD 1.2 billion in 2023-e at a CAGR of 11.1% to touch USD 2.5 billion by 2030. The digital pathology market is dominated by key players such as Philips, Hamamatsu Photonics, Indica Labs, Roche, Hologic, Fujifilm, Paige AI, and Danaher.

According to Intent Market Research, the Vascular Access Device Market is expected to grow from USD 5.2 billion in 2023-e at a CAGR of 7.1% to touch USD 8.9 billion by 2030. The vascular access device market is dominated by key players such as 3M, ICU Medical, Teleflex, AngioDynamics, Medtronic, Argon Medical Devices, and B. Braun.

According to Intent Market Research, the Ultrasound Market is expected to grow from USD 8.1 billion in 2023-e at a CAGR of 5.8% to touch USD 12.1 billion by 2030. The ultrasound market is dominated by key players such as GE Healthcare, Philips, Samsung, Neusoft, Canon Medical Systems, Siemens, and Fujifilm.

According to Intent Market Research, the Digital Dentistry Market is expected to grow from USD 6.9 billion in 2023-e at a CAGR of 10.4% to touch USD 13.8 billion by 2030. The Digital Dentistry Market is dominated by key players such as Dentsply Sirona, Envista Holdings Corporation, 3M, Planmeca, Vatech, Roland DG Corporation, 3D Systems, and Ivoclar Vivadent.

According to Intent Market Research, the Diagnostic Electrocardiograph Market is expected to grow from USD 7.7 billion in 2023-e at a CAGR of 6.4% to touch USD 11.9 billion by 2030. The diagnostic electrocardiograph market is dominated by key players such as GE HealthCare, Philips Healthcare, Nihon Kohden, OSI Systems, Medtronic, Mindray, Schiller AG, and Hill-Rom Holdings.

According to Intent Market Research, the Digital Pharmacy Market is expected to grow from USD 19.4 billion in 2023-e at a CAGR of 9.5% to touch USD 35.9 billion by 2030. The digital pharmacy market is dominated by key players such as Cigna, CVS Health, Walmart, Walgreen, Pharmeasy, Apollo Pharmacy, Amazon, Apex Pharmacy, and Optum, Inc.

According to Intent Market Research, the Optometry Equipment Market is expected to grow from USD 4.3 billion in 2023-e at a CAGR of 6.5% to touch USD 6.7 billion by 2030. The optometry equipment industry market is dominated by key players such as Carl Zeiss Meditec, Alcon, Canon, Bausch Health, Johnson & Johnson, Revenio Group, and NIDEK CO.

According to Intent Market Research, the Spatial Genomics & Transcriptomics Market is expected to grow from USD 4.5 billion in 2023-e at a CAGR of 11.9% to touch USD 9.9 billion by 2030. The spatial genomics & transcriptomics market is competitive; where the prominent players include Illumina, 10X Genomics, Bruker, Bio-Rad Laboratories, Seven Bridges Genomics, Danaher, and PerkinElmer.

According to Intent Market Research, the ERCP market is expected to grow from USD 1.9 billion in 2023-e at a CAGR of 4.0% to touch USD 2.5 billion by 2030. The ERCP market is dominated by key players such as CONMED Corporation, Boston Scientific, B. Braun, Medtronic, Telemed Systems, Steris, Medi-Globe, Olympus, and Fujifilm.

According to Intent Market Research, the veterinary infectious disease diagnostics market is expected to grow from USD 2.3 billion in 2023-e at a CAGR of 9.5% to touch USD 4.3 billion by 2030. The veterinary infectious disease diagnostics market is dominated by key players such as Zeotis, bioMérieux, Qiagen, Heska Corporation, Idexx Laboratories, INDICAL Bioscience, Thermo Fisher Scientific, and MEGACOR.

According to Intent Market Research, the Positron Emission Tomography Market is expected to grow from USD 2.7 billion in 2023-e at a CAGR of 5.0% to touch USD 3.8 billion by 2030. The positron emission tomography market is dominated by key players such as Siemens Healthineers, GE Healthcare, Canon, Philips, Mediso, Oncovision, Kindsway Biotech, and Prescient Medical Imaging.

According to Intent Market Research, the Oncology Information System Market is expected to grow from USD 7.8 billion in 2023 at a CAGR of 7.9% to touch USD 13.3 billion by 2030. The oncology information system market is dominated by key players such as Siemens Healthineers, Philips Healthcare, GE Healthcare, Allscripts Healthcare, IBM, Accuray Incorporated, Epic systems, and Roche.

According to Intent Market Research, the Medical Supplies Market is expected to grow from USD 141.1 billion in 2023-e at a CAGR of 4.1% to touch USD 186.4 billion by 2030. The medical supplies market is dominated by key players such as Cardinal Health, Medtronic, Becton, Dickinson and Company, B. Braun, Abbott, Stryker, 3M, Smith & Nephew, and Thermo Fisher Scientific.

According to Intent Market Research, the Microcatheters Market is expected to grow from USD 0.8 billion in 2023 at a CAGR of 9.2% to touch USD 1.3 billion by 2030. The microcatheters market is competitive; where the prominent players include Boston Scientific, Stryker Corporation, Teleflex Incorporated, Kaneka Corporation, Becton Dickinson and Company, Asahi Intecc, Johnson & Johnson, and Medtronic.

According to Intent Market Research, the Molecular Diagnostics Market is expected to grow from USD 15.8 billion in 2023 at a CAGR of 10.9% to touch USD 32.6 billion by 2030. The molecular diagnostics market is competitive; where the prominent players include Abbott, Illumina, Danaher, Roche Diagnostics, Hologic, Thermo Fisher Scientific, Siemens Healthineers, Becton, Dickinson and Company, and Qiagen.

According to Intent Market Research, the Smart Pills Market is expected to grow from USD 0.6 billion in 2023 at a CAGR of 11.7% to touch USD 1.3 billion by 2030. The Smart Pills Market is competitive; where the prominent players include Medtronic, ElectRx, BodyCap, CapsoVision, IntroMedic, Check-Cap, IntroMedic, AnX Robotica, Olympus, and Otsuka America Pharmaceutical.

According to Intent Market Research, the Stem Cell Therapy Market is expected to grow from USD 5.1 billion in 2023 at a CAGR of 19.3% to touch USD 17.7 billion by 2030. The stem cell therapy market is dominated by key players such as AllCells, ANTEROGEN, Becton, Dickinson, & Company, Takeda Pharmaceutical, RTI Surgical, Merck, Pharmicell, and Thermo Fisher Scientific.

According to Intent Market Research, the Amniotic Products Market is expected to grow from USD 0.9 billion in 2023 at a CAGR of 6.9% to touch USD 1.4 billion by 2030. The amniotic products market is competitive; where the prominent players include Organogenesis, Smith+Nephew, Integra LifeSciences, MIMEDX, Stryker, Tides Medical, and MTF Biologics.

According to Intent Market Research, the High Throughput Screening Market is expected to grow from USD 24.4 billion in 2023 at a CAGR of 11.1% to touch USD 51.0 billion by 2030. The High Throughput Screening Market is competitive; where the prominent players include Thermo Fisher Scientific, Lonza, Agilent Technologies, Eurofins Scientific, Merck, Danaher Corporation, and PerkinElmer.

According to Intent Market Research, the ATP Assays Market is expected to grow from USD 0.3 billion in 2023 at a CAGR of 7.1% to touch USD 0.5 billion by 2030. The ATP Assays Market is competitive; where the prominent players include Thermo Fisher Scientific, Promega Corporation, Merck, PerkinElmer, Agilent Technologies, 3M, and Agilent.

According to Intent Market Research, the Pen Needles Market is expected to grow from USD 1.5 billion in 2023-e at a CAGR of 8.6% to touch USD 2.7 billion by 2030.The Pen Needles market is dominated by key players such as Novo Nordisk, B.Braun, Nipro, Owen Mumford, Arkray and Ultimed.

According to Intent Market Research, the Softgel Capsules Market is expected to grow from USD 1.1 billion in 2023-e at a CAGR of 5.8% to touch USD 1.6 billion by 2030. The Softgel Capsules Market is dominated by key players such as United Laboratories, CAPTEK, Fuji Capsule, Softgel Technologies, Sirio Pharma, and Gelita.

According to Intent Market Research, the Feminine Hygiene Products Market is expected to grow from USD 23.4 billion in 2023-e at a CAGR of 5.0% to touch USD 33.0 billion by 2030. The Feminine Hygiene Products market is dominated by key players such as Kimberly-Clark Corporation, Procter & Gamble, Kao Corporation, Johnson & Johnson, Essity Aktiebolag, and Daio Paper Corporation.

According to Intent Market Research, the Vaccine Adjuvants Market is expected to grow from USD 0.8 billion in 2023-e at a CAGR of 6.5% to touch USD 1.3 billion by 2030. The vaccine adjuvants market is dominated by key players such as Agenus, Dynavax Technologies, Merck, Eubiologics, Hawaii, Aurorium, and Seppic.

According to Intent Market Research, the Vaccines Market is expected to grow from USD 47.7 billion in 2023-e at a CAGR of 9.7% to touch USD 91.2 billion by 2030. The vaccines market is dominated by key players such as Pfizer, Panacea Biotec, Novovax, Daiichi Sankyo, Emergent, CSL, Sanofi, and Bharat Biotec.

According to Intent Market Research, the Analytical Standards Market is expected to grow from USD 1.4 billion in 2023-e at a CAGR of 6.5% to touch USD 2.2 billion by 2030. The Analytical Standards market is dominated by key players such as Merck, Agilent Technologies, Waters Corporation, LGC Standards, Restek Corporation, and PerkinElmer.

According to Intent Market Research, the Clinical Trials Market is expected to grow from USD 45.8 billion in 2023-e at a CAGR of 8.2% to touch USD 79.6 billion by 2030. The clinical trials market is dominated by key players such as Laboratory Corporation of America Holdings, Parexel International Corporation, Icon PLC, IQVIA, Charles River Laboratories, Advanced Clinical, ACM Global Laboratories, and WuXi AppTec.

According to Intent Market Research, the Pharmaceutical Packaging Equipment Market is expected to grow from USD 8.4 billion in 2023-e at a CAGR of 6.5% to touch USD 13.1 billion by 2030. The pharmaceutical packaging equipment market is dominated by key players such as Vanguard Pharmaceutical Machinery, Syntegon Technology, ACG Worldwide, Optima Packaging Group, Trustar Pharma Pack Equipment, MG2 s.r.l., Marchesini Group, Romaco, and Multivac.

Cardiac Safety Services Market was valued at USD 700 million in 2023-e and will surpass USD 1,471 million by 2030; growing at a CAGR of 11.2% during 2024 - 2030.

According to Intent Market Research, the Antimicrobial Resistance Surveillance Market is expected to grow from USD 5.6 billion in 2023-e at a CAGR of 5.1% to touch USD 7.9 billion by 2030. The antimicrobial resistance surveillance market is dominated by key players such as Luminex Corporation, Thermo Fisher, Danaher, Becton, Dickinson and Company, Accelerate Diagnostics, BioSpace, Bio-Rad, Roche, Merck, and Bruker

According to Intent Market Research, the Blood Screening Market is expected to grow from USD 2.3 billion in 2023-e at a CAGR of 6.7% to touch USD 3.6 billion by 2030. The blood screening market is dominated by key players such as Roche, Abbott, bioMérieux, Bio-Rad Laboratories, Siemens Healthineers, Danaher, and Thermo Fisher Scientific.

The Gene Therapy market is projected to grow from USD 8.6 billion in 2023-e to USD 32.4 billion by 2030, registering a CAGR of 20.9% during the forecast period. The Gene Therapy market is dominated by key players such as Novartis, Uniqure, Johnson & Johnson, Orchard Therapeutics, Biogen, Gilead Sciences, Bristol-Myers Squibb, and Sarepta Therapeutics.

According to Intent Market Research, the Antibody Drug Conjugates Market is expected to grow from USD 9.3 billion in 2023-e at a CAGR of 14.7% to touch USD 24.2 billion by 2030. The antibody drug conjugates market is dominated by key players such as Pfizer, Daiichi Sankyo, Seagen, Takeda, Gilead Sciences, Roche, Astellas, ADC Therapeutics, ImmunoGen, AbbVie.

According to Intent Market Research, the Wound Care Market is expected to grow from USD 20.4 billion in 2023-e at a CAGR of 5.4%to touch USD 29.5 billion by 2030. The Wound Care Market is dominated by key players such as Medtronic, 3M, Cardinal Health, Convatec, B. Braun, Paul Hartmann, and Organogenesis.

According to Intent Market Research, the Stem Cell Manufacturing Market is expected to grow from USD 12.1 billion in 2023-e at a CAGR of 10.8% to touch USD 24.8 billion by 2030. The stem cell manufacturing market is competitive; where the prominent players include Thermo Fisher Scientific, Merck, Lonza, Danaher, Sartorius, Becton, Dickinson, and Company, Takara Bio, Getinge, and Eppendorf.

According to Intent Market Research, the Advance Directives Market is expected to grow from USD 116.9 billion in 2023-e at a CAGR of 18.3% to touch USD 378.0 billion by 2030. The advance directives market is dominated by key players such as Iris Healthcare, Bronson Healthcare, Thoroughcare, New Century Health, ADvault, Vynca, WiserCare, and Sharp HealthCare.

According to Intent Market Research, the Molecular Quality Controls Market is expected to grow from USD 0.2 billion in 2023-e at a CAGR of 5.6% to touch USD 0.3 billion by 2030. The Molecular Quality Controls Market is competitive; where the prominent players include Abbott, Danaher, Bio-Rad, Roche, Thermo Fisher Scientific, Grifols, QuidelOrtho, and Randox Laboratories.

According to Intent Market Research, the Multimodal Imaging Market is expected to grow from USD 4.0 billion in 2023-e at a CAGR of 5.2% to touch USD 5.6 billion by 2030. The Multimodal Imaging Market is dominated by key players such as Philips, GE Healthcare, Canon, Siemens Healthineers, Neusoft Corporation, Fujifilm, Bruker, and Topcon Corporation.

According to Intent Market Research, the MRI Systems market is expected to grow from USD 4.9 billion in 2023-e at a CAGR of 4.5% to touch USD 6.7 billion by 2030. The MRI Systems market is dominated by key players such as Philips, Siemens Healthineers, GE Healthcare, Fonar Corporation, Fujifilm, Canon, and Neusoft Medical Systems.

According to Intent Market Research, the Metagenomic Sequencing Market is expected to grow from USD 1.9 billion in 2023-e at a CAGR of 17.0% to touch USD 5.7 billion by 2030. The Metagenomic Sequencing Market is competitive; where the prominent players include Thermo Fisher Scientific, QIAGEN, PerkinElmer, Illumina, Pacific Biosciences, and Eurofins Scientific.

According to Intent Market Research, the Metabolism Assays Market is expected to grow from USD 1.4 billion in 2023-e at a CAGR of 7.3% to touch USD 2.2 billion by 2030. The Metabolism Assays Market is dominated by key players such as, Abcam, Thermo Fisher, Merck, Agilent Technologies, Sartorius, and Mitsubishi Corporation.

According to Intent Market Research, the Medical Equipment Maintenance Market is expected to grow from USD 46.3 billion in 2023-e at a CAGR of 10.1% to touch USD 90.8 billion by 2030. The Medical Equipment Maintenance Market is dominated by key players such as GE Healthcare, Siemens Healthineers, Philips, Medtronic, Hitachi, and B. Braun.

According to Intent Market Research, the Leukapheresis Market is expected to grow from USD 62 million in 2023-e at a CAGR of 7.9% to touch USD 105 million by 2030. The leukapheresis market is dominated by key players such as Asahi Kasei, Fresenius, Terumo BCT, Haemonetics Corporation, Lonza, ZenBio, Macopharma, and Miltenyi Biotec.

Medical Radiation Shielding Market By Product (Lead Sheet, Doors, Windows, Shields, Booths, Curtain, X-Ray), By Solution (Cyclotron, PET, Radiation Therapy, CT, MRI), By End-use (Hospitals, Diagnostic Centers, Clinics & ASCs), and by Region; Global Insights & Forecast (2024 – 2030)

According to Intent Market Research, the Medical Device Testing Market is expected to grow from USD 10.1 billion in 2023-e at a CAGR of 4.4% to touch USD 13.7 billion by 2030. The Medical Device Testing Market is dominated by key players such as Intertek Group, Eurofins Scientific, SGS, Bureau Veritas, Charles River Laboratories, and TÜV SÜD.

According to Intent Market Research, the Label Free Detection Market is expected to grow from USD 0.5 billion in 2023-e at a CAGR of 8.2% to touch USD 0.9 billion by 2030. The label free detection market is competitive; where the prominent players include Danaher, Sartorius, Waters Corporation, PerkinElmer, Attana, Spectris, and Shimadzu Corporation.

According to Intent Market Research, the Insulin Delivery Devices Market is expected to grow from USD 29.2 billion in 2023-e at a CAGR of 8.0% to touch USD 50.0 billion by 2030. The insulin delivery devices market is dominated by key players such as Becton & Dickinson, Eli Lilly, Cerur Corporation, Biocon, Wockhardt, Medtronic, Roche, and Owen Mumford.

According to Intent Market Research, the Intensity Modulated Radiotherapy Market is expected to grow from USD 2.1 billion in 2023-e at a CAGR of 4.8% to touch USD 2.8 billion by 2030. The intensity modulated radiotherapy market is dominated by key players such as Elekta, Siemens Healthineers, Accuray Incorporated, Varian Medical Systems, Brainlab, Philips, and Hitachi.

According to Intent Market Research, the Breast Lesion Localization Market is expected to grow from USD 0.3 billion in 2023-e at a CAGR of 6.1% to touch USD 0.4 billion by 2030. The Breast Lesion Localization Market is dominated by key players such as Intramedical Imaging, GE Healthcare, Becton & Dickinson, Argon Medical, Medline Industries, Hologic, and Dragerwerk.

According to Intent Market Research, the Bone Cement & Glue Market is expected to grow from USD 1.6 billion in 2023-e at a CAGR of 6.0% to touch USD 2.3 billion by 2030. The Bone Cement & Glue Market is dominated by key players such as Stryker, Zimmer Biomet, Smith+Nephew, Medtronic, Cardinal Health, DePuy Synthes, and Enovis.

According to Intent Market Research, the Intraoral/ IOL Scanners Market is expected to grow from USD 0.6 billion in 2023-e at a CAGR of 10.6% to touch USD 1.1 billion by 2030. The Intraoral/ IOL scanners market is competitive; where the prominent players include DENTSPLY SIRONA, Align Technology, Envista, 3shape, Fussen, Launca, 3DISC, and Medit Corp.

According to Intent Market Research, the Blood Culture Tests Market is expected to grow from USD 4.9 billion in 2023-e at a CAGR of 7.5% to touch USD 8.2 billion by 2030. The Blood Culture Tests Market is dominated by key players such as Roche Diagnostics, Becton, Dickinson and Company, Biomérieux, Himedia Laboratories, Scenker Biological Technology, Thermo Fisher Scientific, and Danaher.

According to Intent Market Research, the Incontinence Care Products Market is expected to grow from USD 11.9 billion in 2023-e at a CAGR of 5.1% to touch USD 16.9 billion by 2030. The Incontinence Care Products Market is dominated by key players such as Essity Aktiebolag, Procter & Gamble, Kimberly-Clark, Hartmann, Unicharm, Ontex BV, amongst others

According to Intent Market Research, the Bioimpedance Analyzers Market is expected to grow from USD 0.5 billion in 2023-e at a CAGR of 9.7% to touch USD 1.0 billion by 2030. The Bioimpedance Analyzers Market is dominated by key players such as Tanita Corporation, InBody, EVOLT, OMRON Corporation, RJL Systems, and Seca GmbH.

According to Intent Market Research, the In Vitro Toxicology Testing Market is expected to grow from USD 10.3 billion in 2023-e at a CAGR of 9.0% to touch USD 18.9 billion by 2030. The In Vitro Toxicology Testing Market is dominated by key players such as Thermo Fisher Scientific, SGS, Merck, Eurofins Scientific, Intertek, Laboratory Corporation of America Holdings, Agilent, amongst others.

According to Intent Market Research, the Immunoassay Market is expected to grow from USD 33.3 billion in 2023-e at a CAGR of 5.4% to touch USD 48.2 billion by 2030. The Immunoassay Market is dominated by key players such as Abbott, Roche, Qiagen, Agilent, Thermo Fisher Scientific, Merck, Danaher, Siemens Healthineers, amongst others.

According to Intent Market Research, the Humanized Mouse and Rat Model Market is expected to grow from USD 0.2 billion in 2023-e at a CAGR of 6.0% to touch USD 0.4 billion by 2030. The Humanized Mouse and Rat Model Market is competitive; where the prominent players include Charles River Laboratories, Taconic Biosciences, Crown Bioscience, Amgen, Champions Oncology, Hera BioLabs, among others.

According to Intent Market Research, the Cleanroom Technologies Market is expected to grow from USD 7.8 billion in 2023-e at a CAGR of 6.3% to touch USD 12.0 billion by 2030. The cleanroom technologies market is dominated by key players such as Dynarex, Colandis, ABN Cleanroom Technology, Clean Rooms International, Kimberly-Clark, DuPont, and Illinois Tool Works.

According to Intent Market Research, the Cellulose Ether & Derivatives Market is expected to grow from USD 7.7 billion in 2023-e at a CAGR of 8.6% to touch USD 13.7 billion by 2030. The cellulose ether & derivatives market is dominated by key players such as Dow, Ashland, Fenchem, Shandong Head, Rayonier Advanced Materials, Shin-Etsu Chemical, LOTTE Fine Chemicals, and DKS Co. Ltd.

According to Intent Market Research, the Cell Culture Media Market is expected to grow from USD 5.9 billion in 2023-e at a CAGR of 15.5% to touch USD 16.1 billion by 2030. The cell culture media market is dominated by key players such as Thermo Fisher Scientific, Merck KGaA, Corning Incorporated, Becton & Dickinson, FUJIFILM Irvine Scientific, and Danaher Corporation.

According to Intent Market Research, the HLA Typing for Transplant Market is expected to grow from USD 767 million in 2023-e at a CAGR of 5.8% to touch USD 1,138 million by 2030. The HLA Typing for Transplant Market is dominated by key players such as Thermo Fisher Scientific, Illumina, Roche, Immucor, QIAGEN, CareDX, Bio-Rad Laboratories, among others.

According to Intent Market Research, the Cell Analysis Market is expected to grow from USD 19.2 billion in 2023-e at a CAGR of 10.4% to touch USD 38.4 billion by 2030. The cell analysis market is dominated by key players such Agilent Technologies, Bio-Rad, Illumina, Thermo Fisher Scientific, PerkinElmer, Becton & Dickinson, Standard Biotools, amongst others.

According to Intent Market Research, the Hemostats Market is expected to grow from USD 2.5 billion in 2023-e at a CAGR of 6.2%to touch USD 3.9 billion by 2030. The Hemostats Market is dominated by key players such as Johnson & Johnson, Baxter, Becton & Dickinson, Pfizer, B. Braun, Medtronic, Stryker, among others.

According to Intent Market Research, the Cell Therapy Technologies Market is expected to grow from USD 4.0 billion in 2023-e at a CAGR of 12.8% to touch USD 9.2 billion by 2030. The cell therapy technologies market is dominated by key players such as Thermo Fisher Scientific, Merck, Danaher, Terumo, Becton & Dickinson, Lonza, amongst others.

According to Intent Market Research, the Glycated Albumin Assay Market is expected to grow from USD 0.2 billion in 2023-e at a CAGR of 8.6% to touch USD 0.3 billion by 2030. The Glycated Albumin Assay Market is competitive; where the prominent players include Asahi Kasei, PerkinElmer, Tecan Lifesciences, Agilent, Beijing Strong Biotechnologies, Diazyme Laboratories, DxGen Corp., Weldon Biotech, among others.

According to Intent Market Research, the Animal Genetics Market is expected to grow from USD 6.3 billion in 2023-e at a CAGR of 6.9% to touch USD 10.1 billion by 2030. The animal genetics market is dominated by key players such as Neogen Corporation, Genus, Urus, EW Group, Groupe Grimaud, Topigs Norsvin, CRV Holding, amongst others.

According to Intent Market Research, the AI in Pathology Market is expected to grow from USD 0.01 billion in 2023-e at a CAGR of 14.6% to touch USD 0.1 billion by 2030. The AI in pathology market is dominated by key players such as Koninklijke Philips, Tribun Health, Lumea, Hoffmann-La Roche Ltd, and Hologic.

According to Intent Market Research, the Blood Group Typing Market is expected to grow from USD 1.9 billion in 2023-e at a CAGR of 8.2% to touch USD 3.3 billion by 2030. The blood group typing market is dominated by key players such as Bio-Rad Laboratories, Grifols, QuidelOrtho Corporation, Merck, Quotient, Danaher, Thermo Fisher Scientific, and Immucor.

According to Intent Market Research, the Flow Cytometry Market is expected to grow from USD 4.5 billion in 2023-e at a CAGR of 7.8% to touch USD 7.5 billion by 2030. The Flow Cytometry Market is dominated by key players such as Danaher, Thermo Fisher Scientific, Agilent, bioMérieux, Bio-Rad Laboratories, Becton & Dickinson, among others.

According to Intent Market Research, the Gene Editing Market is expected to grow from USD 5.0 billion in 2023-e at a CAGR of 14.5% to touch USD 12.9 billion by 2030. The Gene Editing Market is competitive; where the prominent players include Merck, Thermo Fisher Scientific, GenScript, Tecan Life Sciences, Agilent, Lonza, PerkinElmer, among others.

According to Intent Market Research, the Adhesion Barrier Market is expected to grow from USD 0.6 billion in 2023-e at a CAGR of 6.9% to touch USD 1.0 billion by 2030. The adhesion barrier market is dominated by key players such as Johnson & Johnson, Becton & Dickinson, Integra LifeSciences, Baxter, Bioscompass, Atrium Medical, Anika Therapeutics, MAST Biosurgery, amongst others.

According to Intent Market Research, the Biotechnology Contract Manufacturing Market is expected to grow from USD 15.8 billion in 2023-e at a CAGR of 7.8% to touch USD 26.8 billion by 2030. The biotechnology contract manufacturing market is dominated by key players such as Catalent, Samsung Biologics, Fujifilm Holdings, Eurofins Scientific, Thermo Fisher Scientific, Lonza, Merck and WuXi Biologics.

According to Intent Market Research, the Biopsy Devices Market is expected to grow from USD 6.2 billion in 2023-e at a CAGR of 13.5% to touch USD 15.1 billion by 2030. The biopsy devices market is dominated by key players such as Becton & Dickinson, Cook Group Incorporated, Hologic, B. Braun, Stryker, Devicor Medical Products, and Olympus Corporation.

According to Intent Market Research, the AI in Medical Diagnostics Market is expected to grow from USD 1.2 billion in 2023-e at a CAGR of 22.6% to touch USD 5.2 billion by 2030. The AI in Medical Diagnostics market is dominated by key players such as Microsoft, Alphabet, NVIDIA Corporation, Merative, GE Healthcare, Digital Diagnostics, Siemens Healthineers, Philips, amongst others.

According to Intent Market Research, the Precision Medicine Market is expected to grow from USD 30.7 billion in 2023-e at a CAGR of 11.4% to touch USD 59.3 billion by 2030. The precision medicine market is competitive, the prominent players in the global market include AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Catalent, Eli Lilly, Gilead Sciences, Johnson & Johnson, Lonza, Merck, Novartis, Parexel, Pfizer, Roche, Sanofi, Takeda Pharmaceutical, amongst others.

According to Intent Market Research, the AI in Drug Discovery Market is expected to grow from USD 850 million in 2023-e at a CAGR of 40.5% to touch USD 4,500 million by 2030. The AI in drug discovery market is a competitive market, the prominent players in the global market include BenevolentAI, BioXcel Therapeutics, Deep Genomics, Exscientia, Google, Insilico Medicine, IQVIA, Labcorp, Microsoft, NVIDIA, and Recursion.